We hypothesized that IV vasopressin would improve the efficacy of oxygenation and increase systemic blood pressure leading to a reduced need for other vasopressor support.

Moreover, the well-known decrease in splanchnic perfusion with both vasopressin and terlipressin is worrisome; splanchnic ischemia is associated with continued systemic inflammatory response ...